Reaction

Neurogenic Bladder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,091 reports · 65 co-occurring drugs

As of the last recalculation, Neurogenic Bladder appears in 2,091 FAERS reports alongside 65 co-occurring drug terms. The strongest observed disproportionality signal is OXYBUTYNIN CHLORIDE (PRR 27.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Oxybutynin Chloride	24	27.6	27.6
Baricitinib	26	27.2	27.2
Baclofen	168	21.0	21.1
Dalfampridine	132	19.5	19.5
Tolterodine Tartrate	16	17.9	17.9
Tizanidine Hydrochloride	29	16.2	16.2
Magnesium Hydroxide	21	15.7	15.7
Ocrelizumab	92	15.4	15.4
Oxybutynin	41	14.2	14.2
Dronabinol	11	13.7	13.7
Bisacodyl Suppositories	17	13.2	13.2
Biscodyl	17	13.1	13.1
Alemtuzumab	25	13.0	13.0
Amantadine	20	13.0	13.0
Fingolimod Hcl	106	12.8	12.8
Natalizumab	211	12.7	12.8
Nitrofurantoin (Monohydrate/Macrocrystals)	21	12.6	12.6
Siponimod	11	12.3	12.3
Docusate Sodium - Sennosides	39	12.3	12.3
Nitrofurantoin	20	12.2	12.2
Interferon Beta-1A	214	12.2	12.2
Ascorbic Acid	28	12.1	12.1
Bisacodyl	17	12.1	12.1
Mirabegron	44	11.5	11.6
Modafinil	35	11.0	11.0
Standardized Senna Concentrate	13	10.3	10.4
Chlorhexidine Gluconate	9	9.8	9.9
Pitavastatin Calcium	10	9.8	9.8
Cladribine	9	9.4	9.4
Fesoterodine Fumarate	10	9.2	9.2
Docusate Sodium	51	9.0	9.0
Polyethylene Glycol	9	8.3	8.3
Sennosides 8.6 Mg Tablets	17	8.1	8.1
Senna	17	8.1	8.1
Meclizine Hcl 12.5Mg	11	8.1	8.1
Meclizine Hcl 25Mg	11	8.1	8.1
Meclizine Hcl 12.5 Mg	11	8.1	8.1
Meclizine Hcl 25 Mg	11	8.1	8.1
Senna Leaf	18	7.8	7.8
Bortezomib	67	7.7	7.7
Tizanidine	18	7.6	7.6
Vibegron	6	7.5	7.5
Lubiprostone	7	7.4	7.4
Meclizine Hydrochloride	14	7.2	7.2
Trazodone Hydrochloride	11	7.0	7.0
Glatiramer Acetate	41	6.9	7.0
Diroximel Fumarate	8	6.7	6.7
Tocilizumab	72	6.5	6.5
Teriflunomide	29	6.5	6.5
Polyethylene Glycol 3350	59	6.3	6.3
Interferon Beta-1B	12	6.3	6.3
Iohexol	5	6.0	6.0
Thalidomide	21	5.7	5.7
Dimethyl Fumarate	67	5.6	5.6
Peginterferon Beta-1A	7	5.3	5.3
Armodafinil	11	5.2	5.2
Ofatumumab	17	5.1	5.1
Tolvaptan	7	4.8	4.8
Eszopiclone	12	4.7	4.7
Certolizumab Pegol	43	3.7	3.7
Umeclidinium Bromide And Vilanterol Trifenatate	6	3.6	3.6
Onabotulinumtoxina	25	3.3	3.3
Axicabtagene Ciloleucel	3	3.0	3.0
Droxidopa	4	1.8	1.8
Galcanezumab-Gnlm	5	1.6	1.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.